Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Community Health Systems
CYH
$423M
| $1.8M | ﹤0.01% |
612,153
-10,994
| -2% | -$35.6K |
|
|
OTF
2852
Blue Owl Technology Finance Corp
OTF
$5.25B
| $1.8M | ﹤0.01% |
145,153
+20,728
| +17% | +$264K |
|
2853
FS KKR Capital
FSK
$3.42B
| $1.79M | ﹤0.01% |
176,040
+57,042
| +48% | +$714K |
|
2854
Amplitude
AMPL
$1.63B
| $1.79M | ﹤0.01% |
262,530
-1,453
| -0.6% | -$12K |
|
2855
Central Garden & Pet Co
CENT
$2.74B
| $1.79M | ﹤0.01% |
48,568
-2,451
| -5% | -$87.7K |
|
2856
Emergent Biosolutions
EBS
$235M
| $1.78M | ﹤0.01% |
215,043
-29,469
| -12% | -$305K |
|
2857
ACNB Corp
ACNB
$660M
| $1.78M | ﹤0.01% |
37,274
+2,846
| +8% | +$140K |
|
2858
Beazer Homes USA
BZH
$872M
| $1.78M | ﹤0.01% |
92,707
+5,741
| +7% | +$133K |
|
2859
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.25B
| $1.78M | ﹤0.01% |
37,001
| – | – |
|
|
RGLO
2860
Russell Investments Global Equity ETF
RGLO
$360M
| $1.78M | ﹤0.01% |
61,479
+7,655
| +14% | +$230K |
|
2861
UroGen Pharma
URGN
$2.36B
| $1.78M | ﹤0.01% |
98,942
+113
| +0.1% | +$2.27K |
|
2862
Bit Digital
BTBT
$566M
| $1.78M | ﹤0.01% |
1,356,428
-7,966
| -0.6% | -$14.6K |
|
2863
Legend Biotech
LEGN
$3.95B
| $1.77M | ﹤0.01% |
97,613
-5,762
| -6% | -$110K |
|
2864
Trip.com Group
TCOM
$28.3B
| $1.76M | ﹤0.01% |
35,446
-985
| -3% | -$57.4K |
|
2865
Red River Bancshares
RRBI
$676M
| $1.76M | ﹤0.01% |
19,481
-223
| -1% | -$18.9K |
|
2866
VanEck Gold Miners ETF
GDX
$27.5B
| $1.76M | ﹤0.01% |
19,177
+12,113
| +171% | +$1.19M |
|
2867
Kodak
KODK
$979M
| $1.76M | ﹤0.01% |
194,139
-40,544
| -17% | -$309K |
|
2868
iShares Core MSCI Europe ETF
IEUR
$9.15B
| $1.76M | ﹤0.01% |
24,996
+16,926
| +210% | +$1.24M |
|
2869
Omeros
OMER
$1.24B
| $1.76M | ﹤0.01% |
166,246
+464
| +0.3% | +$5.47K |
|
2870
Choiceone Financial
COFS
$514M
| $1.75M | ﹤0.01% |
62,406
+2,114
| +4% | +$60.6K |
|
|
PML
2871
PIMCO Municipal Income Fund II
PML
$493M
| $1.74M | ﹤0.01% |
230,269
-58,132
| -20% | -$446K |
|
2872
indie Semiconductor
INDI
$995M
| $1.74M | ﹤0.01% |
540,803
-28,225
| -5% | -$99.7K |
|
2873
Blue Owl Capital
OBDC
$5.78B
| $1.74M | ﹤0.01% |
157,390
+18,740
| +14% | +$220K |
|
2874
ArriVent BioPharma
AVBP
$1.46B
| $1.74M | ﹤0.01% |
75,448
+2,337
| +3% | +$52.8K |
|
2875
Inhibrx
INBX
$1.3B
| $1.74M | ﹤0.01% |
25,874
-874
| -3% | -$64.8K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.